Teiko.Bio
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. The company was founded in 2020 and is based in Salt Lake City, Utah.
Last updated on
About Teiko.Bio
Employees
11-50Funding / Mkt. Cap
$12MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
San FranciscoState
CaliforniaCountry
United StatesTeiko.Bio
Find your buyer within Teiko.Bio
Tech Stack (36)
